For providers
Provider resources

Resources designed to support your practice

Access resources to help understand the utility, value, and applicability of the Oncotype DX Breast Recurrence Score® test—and materials to use with patients. 

Guidelines

TAILORx trial

The Trial Assigning Individualized Options for Treatment (Rx), TAILORx, is the largest randomized adjuvant breast cancer trial. 

Pathology guidelines

PDF
Learn how to choose a tissue specimen for testing.

ASCO guidelines

Updated ASCO guidelines strongly recommend using the Oncotype DX Breast Recurrence Score test for patients with node-negative, and for the majority of those with node-positive, early-stage breast cancer.1

Forms

Test Requisition form

PDF
To place an Oncotype DX® order for a patient, please complete the Oncotype DX Breast Recurrence Score form through our Provider Hub. You may also print a form, complete it, and fax it to 866-444-0640. 
A doctor seated at a desk looking at his laptop.

Ordering a test for your patients is fast and easy

Order tests, access results, and receive updates through our Provider Hub.

Have questions?

Call us at 1 866-662-6897.

References

  1. Andre F, Ismaila N, Allison KH, et al. Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update. J Clin Oncol. 2022;40(16):1816-1837.